BIOLOGY OF SICKLE CELL DISEASE

镰状细胞病的生物学

基本信息

  • 批准号:
    3098179
  • 负责人:
  • 金额:
    $ 96.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-12-01 至 1993-11-30
  • 项目状态:
    已结题

项目摘要

A group of several independent scientists at The University of Chicago seeks to create a coordinated program in sickle cell disease research. Their approaches vary widely, but they share a common interest: the erythrocyte in health and disease, sickle cell disease in particular. Their aims are to draw closer together around the topic of sickle cell disease; to create a highly interactive scientific group whose diverse interests will be synergistic; to foster new and better research, both individual and collaborative; and to expedite such research through coordinated sharing of scientific information, instrumentation, core facilities, patients, and data. The benefits of the program project will be the promotion of mutual education, new scientific insights, improved collaboration, and increased efficiency and economy of research through a central focus on sickle cell disease. This application seeks support for this program. The theme of this program is the biology of the erythrocyte in sickle cell disease. In that the research emanates from independent scientific programs, it is not unitary but diverse and complementary. The program thus draws strength from the breadth of its membership and a wide range of expertise. There is, nevertheless, considerable continuity in the scope of the research. Huttenlocher seeks to relieve the occlusive cerebral vascular disease arising from the compromised rheology of sickled cells. Shen proposes to elucidate the structural basis for the irreversibly-sickled cell; an altered sub-membrane filamentous network. Josephs will continue his characterization of hemoglobin S fibers by high resolution electron microscopy. Potel will apply computer techniques to the analysis of Josephs's EM data and Huttenlocher's positron emission tomographs. Steck will test a novel hypothesis which explains and promises to reverse the increased passive permeability of sickle cell membranes to small solutes. Goldwasser will study the expression of globin genes and Gross will study the control of their translation. Not all projects interact with all others; this would be an unrealistic goal for research programs that originate with investigators rather than with a single organizer. There is, however, a stong element of mutual interest that is bound to help advance the science in each subproject.
芝加哥大学的几位独立科学家组成的小组

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EUGENE GOLDWASSER其他文献

EUGENE GOLDWASSER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EUGENE GOLDWASSER', 18)}}的其他基金

REGULATION OF ERYTHROPOIETIN AND HEMOGLOBIN GENE EXPRESSION
促红细胞生成素和血红蛋白基因表达的调节
  • 批准号:
    6109700
  • 财政年份:
    1998
  • 资助金额:
    $ 96.35万
  • 项目类别:
REGULATION OF ERYTHROPOIETIN AND HEMOGLOBIN GENE EXPRESSION
促红细胞生成素和血红蛋白基因表达的调节
  • 批准号:
    6241799
  • 财政年份:
    1997
  • 资助金额:
    $ 96.35万
  • 项目类别:
BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    937852
  • 财政年份:
    1995
  • 资助金额:
    $ 96.35万
  • 项目类别:
THE BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    3098180
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    2216589
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    2216592
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    1101995
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
THE BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    3098168
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
THE BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    3098177
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:
THE BIOLOGY OF SICKLE CELL DISEASE
镰状细胞病的生物学
  • 批准号:
    3098178
  • 财政年份:
    1988
  • 资助金额:
    $ 96.35万
  • 项目类别:

相似国自然基金

时空分辨核酸生物传感在亚细胞水平光电双模态精准测量
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
水凝胶改性陶瓷人工关节牢固结合界面的构筑与减磨润滑机理研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
锆酸铅基反铁电体畴动力学及其调控机理研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
USP7维持FADS2蛋白质稳态调控线粒体重编程驱动三阴性乳腺癌的转移
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
载铁生物炭对土壤镉污染的吸附固定及微生物协同作用机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
SREBP转录因子BbSre1负调控球孢白僵菌抗真菌物质产生的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
面向截肢患者运动感知重建的肌电假肢手关节运动反馈时变编码研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
载鸢尾素层层自组装二氧化钛纳米管材料促进糖尿病骨缺损修复及机制研
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
多源数据融合的内外激励耦合下电驱动系统非平稳非高斯服役载荷谱高保
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
面向水质应急快检的碳点/微流控限域增强发光传感研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 96.35万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 96.35万
  • 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
  • 批准号:
    10382052
  • 财政年份:
    2022
  • 资助金额:
    $ 96.35万
  • 项目类别:
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA
患有镰状细胞性贫血的初潮后女性的卵巢储备
  • 批准号:
    10690200
  • 财政年份:
    2022
  • 资助金额:
    $ 96.35万
  • 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
  • 批准号:
    10551233
  • 财政年份:
    2022
  • 资助金额:
    $ 96.35万
  • 项目类别:
Investigating the interplay between Sickle Cell Anemia and Malaria at the epidemiological and molecular levels.
在流行病学和分子水平上研究镰状细胞性贫血和疟疾之间的相互作用。
  • 批准号:
    463824
  • 财政年份:
    2022
  • 资助金额:
    $ 96.35万
  • 项目类别:
    Operating Grants
Microvascular Cerebral Blood Flow Monitoring with Diffuse Correlation Spectroscopy in Sickle Cell Anemia Children
镰状细胞性贫血儿童的弥散相关光谱微血管脑血流监测
  • 批准号:
    10597513
  • 财政年份:
    2021
  • 资助金额:
    $ 96.35万
  • 项目类别:
The Impact of Cerebral Metabolic Stress on the Development of the Structural and Functional Connectome in Pediatric Sickle Cell Anemia
脑代谢应激对小儿镰状细胞贫血症结构和功能连接体发育的影响
  • 批准号:
    10179749
  • 财政年份:
    2021
  • 资助金额:
    $ 96.35万
  • 项目类别:
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach
优化镰状细胞性贫血儿童预防服务接受的机会:混合方法
  • 批准号:
    10469404
  • 财政年份:
    2021
  • 资助金额:
    $ 96.35万
  • 项目类别:
The Impact of Cerebral Metabolic Stress on the Development of the Structural and Functional Connectome in Pediatric Sickle Cell Anemia
脑代谢应激对小儿镰状细胞贫血症结构和功能连接体发育的影响
  • 批准号:
    10594416
  • 财政年份:
    2021
  • 资助金额:
    $ 96.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了